No abstract available
MeSH terms
-
Abciximab
-
Acute Disease
-
Aged
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Anticoagulants / adverse effects*
-
Anticoagulants / therapeutic use
-
Combined Modality Therapy
-
Drug Therapy, Combination
-
Hemoptysis / chemically induced*
-
Hemoptysis / therapy
-
Humans
-
Immunoglobulin Fab Fragments / adverse effects*
-
Immunoglobulin Fab Fragments / therapeutic use
-
Male
-
Myocardial Infarction / drug therapy
-
Myocardial Infarction / surgery*
-
Percutaneous Coronary Intervention / methods*
-
Postoperative Hemorrhage / chemically induced*
-
Postoperative Hemorrhage / diagnosis
-
Postoperative Hemorrhage / therapy
-
Pulmonary Embolism / diagnosis*
-
Pulmonary Embolism / drug therapy
-
Pulmonary Embolism / etiology
Substances
-
Antibodies, Monoclonal
-
Anticoagulants
-
Immunoglobulin Fab Fragments
-
Abciximab